Low-Dose Metronomic Capecitabine (Xeloda) for Treatment ofMetastatic Cholangiocarcinoma : Case Reports and Review of the Literature | Semantic Scholar
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
Total Health | VuMedi
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
JCM | Free Full-Text | Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer—A Retrospective Analysis of Consecutive Patients Data
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation | SpringerLink
Metronomic capecitabine showed no significant myelosuppression. A and... | Download Scientific Diagram
Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients' T cell ferroptosis
A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer,Thoracic Cancer - X-MOL
Metronomic chemotherapy in mbc | PPT
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis
PDF) A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
PDF) Metronomic capecitabine as maintenance treatment after first line induction with XELOX for metastatic colorectal cancer patients
Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial) | Future Oncology
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure - ScienceDirect
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
Frontiers | Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
Metronomic capecitabine maintenance extends DFS in triple-negative breast cancer
Frontiers | Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer | Trials | Full Text
Low-Dose Metronomic Capecitabine (Xeloda) for Treatment ofMetastatic Cholangiocarcinoma : Case Reports and Review of the Literature | Semantic Scholar
Possible immunosuppressive mechanisms of metronomic capecitabine on T... | Download Scientific Diagram
Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
Low-dose capecitabine (Xeloda) for treatment for gastrointestinal cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
